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The  present  study  investigated  in vitro  the  effects  of  sulphated  heterorhamnan  (Go3),  iota-/nu-
carrageenans  (G3d  and  EHW-I)  and  arabinogalactan  (ARAGAL)  polysaccharides  on  macrophage  activation
and inhibition  of intracellular  amastigotes  of  Leishmania  (L.)  amazonensis.  All  the sulphated  polysaccha-
rides  (Go3,  G3d  and EHW-I)  promoted  increased  nitric  oxide  production  varying  from  71 to 110%.  The
leishmanicidal  activity  of  all compounds  was  compared  to the  inhibition  effect  of  Meglumine  Antimo-
niate  at  300  g/mL  (∼79%),  used  as  positive  control.  Inhibition  of Leishmania  (L.)  amazonensis  growtholysaccharides
acrophages
eishmania
was  55%  with  5 g/mL  of Go3,  50%  and  98%  to G3d  and  EHW-I,  respectively  at 10  g/mL,  and  88% with
10 g/mL  of  ARAGAL.  The  superoxide  anion  scavenging  activity  for  the  sulphated  polysaccharides  var-
ied  from  approximately  30–55%  at 10  g/mL.  In conclusion,  the  results  of  the present  study  indicate  the
promising  potential  of  these  polysaccharides  for  the  development  of  new  alternative  therapeutic  agents
against  leishmaniasis.. Introduction
Leishmaniasis is an anthropozoonosis considered one of world’s
ix major infectious diseases due to its high detection rate and
ts ability to produce deformities [1]. This disease is caused by
nfection by protozoan parasites of the genus Leishmania, a mem-
er of the family Trypanosomatidae.  It is transmitted to mammals
hrough the bite of female invertebrates of the subfamily Phle-
otominae, a sandﬂy [2]. In the mammalian host, parasites live
nside macrophage cells and develop several strategies to escape
rom immune responses [3,4]. The treatment of leishmaniasis
s based on pentavalent antimonials (PVAs), which have been
sed for over six decades [5]. This chemotherapy is known for
ts serious side effects and the emergence of resistance of the
arasites to antimony. Although, the leishmanicidal mechanism
xerted by PVAs is not well understood, evidences have suggested
hat the leishmanicidal effects exhibited by these drugs require, in
art, host cell response [6]. Once activated, macrophages produce
∗ Corresponding author at: Departamento de Bioquímica e Biologia Molecular,
etor de Ciências Biológicas, Centro Politécnico, Universidade Federal do Paraná,
.P. 19046, CEP 81530-980 Curitiba, PR, Brazil.
E-mail address: iacomini@ufpr.br (M. Iacomini).
ttp://dx.doi.org/10.1016/j.ijbiomac.2015.07.006
141-8130/© 2015 Elsevier B.V. All rights reserved.© 2015  Elsevier  B.V.  All  rights  reserved.
different cytokines, reactive oxygen and nitrogen species, which
are important to microbicidal activity exerted by these cells [7].
Thus, compounds that are able to activate macrophages to produce
these and other mediators could present leishmanicidal activity.
Therefore, the immunochemotherapy should be considered as
an alternative modality for the treatment of leishmaniasis [6,8].
Polysaccharides of various sources and with different structural
characteristics have been classiﬁed as immunomodulators because
they increase the speed or prolong the duration of the speciﬁc
immune response [9–12]. It has been proposed that polysaccha-
rides can bind to macrophage membrane receptors and activate
these cells in various ways, promoting speciﬁc responses as anti-
tumor and antimicrobial [9,13,14]. Among the receptors already
characterized on macrophages that recognize polysaccharides
include Toll-like receptor (TLR); scavenger receptor (SR); comple-
ment receptor type 3 (CR3); MR,  mannose receptor (MR); mannan
binding lectin (MBL) as revised [15]. The binding of polysaccha-
rides at receptors on macrophages can stimulate these cells to
trigger different process like enhance of phagocytosis, production
of mediators as reactive oxygen and nitrogen species, and different
cytokines, which act as effectors in immunological response [9]. In
this sense, many studies aiming to evaluate the immunomodula-
tory potential of polysaccharides have been performed in recent
decades.
1 urnal 
r
s
m
A
i
a
m
m
g
a
t
i
p
n
b
R
r
t
S
r
c
a
h
A
n
m
a
i
a
a
2
2
(
(
d
s
f
w
m
C
a
a
s
w
2
l
h
a
(
o
r
2
c
r
[
a66 M.M. Kangussu-Marcolino et al. / International Jo
In previous study, arabinogalactan (ARAGAL) stimulated the
eleasing of tumour necrosis factor- (TNF-)  in mouse and
howed a signiﬁcant effect against Sarcoma 180 (S-180) tumour
odel [16]. The authors suggested that the antitumor activity of
RAGAL may  be due to its immunomodulatory effects, since it
ncreased the number of activated macrophages and superoxide
nion production by these cells in mouse treated with the poly-
er  [12]. In macrophages infected with Leishmania, this activation
ay culminate in killing the intracellular parasites. Accordingly,
alactomannan (GMPOLY) isolated from lichen Ramalina celastri
nd an arabinomannose (Z-100) extracted from Mycobacterium
uberculosis have been classiﬁed as macrophage activators exhibit-
ng leishmanicidal effect in vitro [17,18]. The use of the chitosan
olymer as a vehicle in the preparations of meglumine antimo-
iate or doxorubicin for experimental leishmaniasis treatment has
een investigated and promising results has been observed [19,20].
ecently, mannose-conjugated chitosan nanoparticles loaded with
ifampicin, aiming a selective delivery of rifampicin for the
reatment of visceral leishmaniasis has been investigated [21].
ulphated polysaccharides also have been studied as biological
esponse modiﬁers [22]. Sulphated heterorhamnan (Go3), iota-/nu-
arrageenan fraction (G3d) and fraction (EHW-I) exhibited antiviral
ctivity against herpes simplex [23–25].
Considering the need to ﬁnd alternative treatments for
uman leishmaniasis, the immunomodulatory effects exhibited by
RAGAL [12,16], the absence of study with sulphated heterorham-
an (Go3), iota-/nu-carrageenan fractions (G3d and EHW-I) on
acrophages and Leishmania, and the leishmanicidal activity
lready observed in some polysaccharides [17,26–28], this study
nvestigated the effect of different polysaccharides on macrophage
ctivation and on viability of amastigote forms of Leishmania (L.)
mazonensis in vitro.
. Materials and methods
.1. Material
Phorbol 12-myristate 13-acetate (PMA), lipopolysaccharides
LPS), N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid
HEPES), ferricytochrome c, superoxide dismutase (SOD) (3-[4,5-
imethylthiazol-2-yl]-2,5-diphenyl-tetrazolium bromide) (MTT),
ulphanilamide, and naphthyl ethylenediamine were obtained
rom Sigma Chemical Co. (St Louis, MO). Tissue culture materials
ere supplied by Corning or Nunc A/S. Eagle’s minimum essential
edium (MEM)  and foetal bovine serum were obtained from
ultilab (Brazil), bacteriological agar, bacteriological peptone
nd beef extract from Himedia and Glucantime® (Meglumine
ntimoniate) from Aventis. The PMA  was dissolved in Me2SO and
tored at −20 ◦C as a 1 mg/mL  stock solution. All the other reagents
ere commercial products of the highest purity available.
.2. Polysaccharides
The arabinogalactan (ARAGAL) used in this study was iso-
ated from Anadenanthera colubrina and characterized [29], the
eteropolysaccharide has a (1,3)-linked -d-Galp main-chain
nd many different side-chains. Sulphated heterorhamnan Go3
26.1% sulphate) was extracted from the green seaweed Gayralia
xysperma [23], the backbone is constituted by 3- and 2-linked
hamnosyl units with ratio (1.0:0.8) and side chains containing
-sulphated glucuronic and galacturonic acids. The iota-/nu-
arrageenan fraction, G3d (29.4% sulphate) was extracted from the
ed seaweed Gymnogongrus grifﬁthsiae,  as previously described
24]. This carrageenan is composed of iota (70%), nu- (17%)
nd kappa (13%) diads [25]. Ground red seaweed Eucheumaof Biological Macromolecules 81 (2015) 165–170
denticulatum was  subjected to aqueous extraction at 25 ◦C for 3 h.
After centrifugation, the pellet was  extracted with water at 80 ◦C
for 3 h to yield the EHW-I fraction (31% sulphate). The 1H NMR
analysis of EHW-I showed signals at 5.33 and 5.52 ppm, which cor-
respond, respectively, to H1 of 3,6-anhydro--d-galactopyranose
2-sulphate and H1 of -d-galactopyranose 2,6-disulphate [30].
These results indicated that EHW-I contains a hybrid iota-
/nu-carrageenan (ratio 77:23), as previously reported for the
carrageenan-producing E. denticulatum red seaweed [31]. The 1H
NMR  analysis spectrum of EHW-I is included in the supplementary
data.
The polysaccharides were dissolved in ultrapure water, ster-
ilized by ﬁltration through a 0.22 m membrane, and their
concentrations determined by the phenol–sulphuric acid method
[32]. For the purpose of control in case of an eventual LPS contam-
ination, samples of polysaccharides were analyzed by GC–MS [33],
but showed no signal of the presence of LPS (data not shown).
2.3. Leishmania culture
Leishmania (Leishmania) amazonensis (designated MHOM/BR/
73/M2269) promastigotes were cultured at 26–28 ◦C in Evans’
modiﬁed Tobie’s medium (EMTM), and in the exponential phase
transferred and maintained in MEM  medium supplemented with
10% heat-inactivated foetal bovine serum, 100 U/mL penicillin,
100 g/mL streptomycin, and 50 g/mL gentamicin.
2.4. Peritoneal macrophage preparation
Swiss mice (6–8 weeks old) provided by biotery of Biolog-
ical Campus of Federal University of Paraná have received a
standard laboratory diet (Purine) were used to obtain peritoneal
macrophages. All the legal recommendations of Brazilian legisla-
tion (Law No. 6.638,05 Nov. 1979) for animal handling procedures
for scientiﬁc research were approved by the Animal Ethics Com-
mittee. The peritoneal macrophages were collected by infusing the
donors’ peritoneal cavity with 8–10 mL  of chilled sterile phosphate-
buffered saline (PBS). The cells were plated in a culture medium
(minimum essential medium-MEM, 5% foetal bovine serum and
antibiotics) or HBSS in 24 or 96-well plates (5 × 105 cells/well).
After 1–2 h of incubation at 37 ◦C under 5% CO2 in a humidiﬁed incu-
bator, non-adherent cells were removed by washing twice with PBS
at 37 ◦C.
2.5. Cytotoxicity assays
Adherent macrophages in 96-well plates were incubated for
48 h in the absence (control) or presence of ARAGAL, Go3, G3d
and EHW-I at various concentrations (5–100 g/mL). Cell viability
was evaluated using 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenylte-
trazolium bromide (MTT), as previously described [34].
2.6. Measurement of superoxide anion production
Adherent macrophages in 96-well plates were incubated in a
standard reaction mixture consisting of HBSS containing ferricy-
tochrome c (80 M)  in the presence or absence of PMA  (1 g/mL).
Go3, G3d and EHW-I (25–100 g/mL) were added to the standard
reaction mixture. Controls were prepared without polysaccharides,
and with adequate amounts of DMSO (solvent of PMA). Absorbance
was measured at 550 nm after 2 h and the amount of superoxide
anion released was  calculated as previously demonstrated [35]. The
concentration of reduced cytochrome c was  determined using the
molar extinction coefﬁcient = 2.1 × 104 M−1 cm−1. The results are
expressed in mol  of reduced cytochrome c per 5 × 105 cells.
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Table 1
Effects of the polysaccharides ARAGAL, Go3, G3d and EHW-I on intracellular
amastigotes evaluated by the growth of promastigote forms.
Concentration
(g/mL)
Leishmania amazonensis
(% promastigotes/mL)
Medium – 99.6 ± 4.7
Meglumine antimoniate 300 20.1 ± 8.3*
ARAGAL 10 11.4 ± 4.2*
25 10.4 ± 5.0*
50 8.5 ± 3.0*
Go3 2.5 82.2 ± 8.2
5  51.7 ± 7.1*
10 44.5 ± 5.7*
G3d 2.5 70.3 ± 4.1*
5 60.6 ± 5.0*
10 48.9 ± 4.3*
EHW-I 2.5 2.5 ± 0.6*
5 7.7 ± 2.4*
10 1.7 ± 0.6*
(1 g/mL), an agent that triggers respiratory burst in vitro. Go3,
G3d or EHW-I were able to reduce superoxide anion production
by up to ∼97% at 100 g/mL in the absence of PMA  (Fig. 3a). In
Fig. 1. Effects of Go3, G3d and EHW-I on the viability of peritoneal macrophages.M.M. Kangussu-Marcolino et al. / International Jo
.7. Measurement of nitric oxide production
Adherent macrophages in 96-well plates were incubated with
o3, G3d and EHW-I (2.5–10 g/mL) and LPS (100 ng/mL), used
s positive control. After 48 h, the NO production was indirectly
ssessed by measuring nitrite in the culture medium using the
riess reaction [36] with modiﬁcations. The isolated supernatants
ere mixed with an equal volume of Griess reagent and incubated
t 25 ◦C for 10 min. Absorbance was measured at 550 nm and the
itrite concentration was calculated from a NaNO2 standard curve.
he results are expressed as mol  per 5 × 105 cells.
.8. Measurement of intracellular parasite killing
The polysaccharide activity on intracellular amastigotes was
easured as described by [17]. Peritoneal macrophages were
lated in 24-well plates (5 × 105 cells/well) and left to adhere for
 h. Non-adherent cells were removed and macrophages were
nfected with promastigotes (5 parasites per macrophage), fol-
owed by 12 h of incubation at 34 ◦C in the presence of 5%
O2. Infected macrophages were washed twice with PBS and re-
ncubated in a medium containing Go3, G3d, EHW-I (2.5–10 g/mL)
r ARAGAL (10–50 g/mL). After 48 h at 37 ◦C with 5% CO2. After
hat, the cells were scraped off, suspended in saline (0.4 mL)  and
hen transferred to EMTM,  followed by incubation for 5–10 days
t 24 ◦C. Promastigote densities were determined microscopically
sing a Neubauer haemocytometer and are expressed in percentage
f promastigotes per mL.
.9. Measurement of scavenging superoxide anion
The scavenging ability of superoxide radical was assessed by
he method described by Nishikimi et al. [37], with modiﬁcations.
n this assay, reduced nicotinamide adenine dinucleotide (NADH)
eacted to phenazine methosulphate (PMS) generating superoxide
adicals which reduced nitro-blue tetrazolium (NBT). The reaction
ystem consisted of Tris–HCl 10 mM (pH 8.0), NADH 340 M,  NBT
2 M and PMS  30 M.  The addition of NADH triggered the reac-
ion, which was monitored at 560 nm for 5 min  in the absence or
resence of Go3, G3d or EHW-I at 2.5, 5 and 10 g/mL. The super-
xide radical scavenging capacity was calculated as described by
38].
.10. Statistical analysis
The data were analyzed statistically by variance analysis and
ukey’s test for comparison of averages. Mean values ± S.D. were
sed, and values were considered signiﬁcant when P < 0.05.
. Results
.1. Effects of ARAGAL, Go3, G3d and EHW-I on intracellular
mastigote of Leishmania Leishmania amazonensis
The effect of polysaccharides on amastigote forms of Leishmania
L.) amazonensis was evaluated indirectly by counting promastig-
te forms. Infected and treated macrophages were scraped off the
lates and transferred to EMTM,  enabling the living parasites to
eave the macrophage and proliferate as promastigote forms, which
re countable. The results shown in Table 1 indicate considerable
rowth of Leishmania (L.) amazonensis in infected but untreated
ells. Go3 and G3d inhibited growth by almost 50% at 10 g/mL.
HW-I showed the most intense effect, inhibiting Leishmania (L.)
mazonensis growth by up to ∼98% at 10 g/mL. ARAGAL also
romoted strong inhibitory activity of Leishmania growth of up
o ∼88–91% at 10 and 50 g/mL, respectively. Both ARAGAL andThe results are expressed as mean ± SE (n = 4, each experiment in triplicate).
* p ≤ 0.05 signiﬁcant difference from negative control (medium).
EHW-I exhibited a stronger effect than that of the positive con-
trol, Meglumine Antimoniate ∼79% (300 g/mL), which is currently
used to treat leishmaniasis.
3.2. Effects of Go3, G3d, and EHW-I on peritoneal macrophage
activity and superoxide anion scavenging
The effects of the sulphated polysaccharides Go3, G3d and EHW-
I on production of reactive oxygen and nitrogen species in these
cells, which are related to leishmanicidal activity [39], were eval-
uated. All experiments were carried out in concentrations that are
not cytotoxic to macrophages (Figs. 1 and 4a).
The effects of polysaccharides on NO production by
macrophages were determined in 48 h of incubation. These
results are depicted in Fig. 2. Go3 (Fig. 2a) promoted increased
NO production of up to ∼120% at 2.5 g/mL, which was  similar
at 5 and 10 g/mL. The effect of EHW-I was less intense (Fig. 2a),
reaching up to 81% of stimulation when compared with the
medium. G3d (Fig. 2b) exhibited a stimulatory effect of up to 71%
at 10 g/mL, while ARAGAL (Fig. 4b) showed no effect on nitric
oxide production.
To determine whether the compounds could affect respiratory
burst in macrophages, these cells were exposed to 25–100 g/mL
of Go3, G3d or EHW-I for 2 h in the presence or absence of PMAMurine peritoneal macrophages were exposed for 48 h to the polysaccharides Go3,
G3d, EHW-I at the indicated concentrations. Cell viability was determined by MTT
assay. Culture medium was used as negative control, corresponding to 100% viabil-
ity.  The results are expressed as mean ± SD (n = 3, each experiment in quadruplicate).
*p ≤ 0.05 signiﬁcant difference from negative control (medium).
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cig. 2. Nitric oxide production by peritoneal macrophages after 48 h of exposure to
ethod. The results are expressed as mean ± SE (n = 3, each experiment in triplicate
he presence of PMA, this reduction reached up to 92% with Go3,
7% with G3d and 78% with EHW-I at 100 g/mL (Fig. 3b). The
onsiderable inhibition of respiratory burst by the polysaccharides
uggests they possess scavenging ability [38].
In view of this evidence, polysaccharides ability to capture
uperoxide anion was evaluated using nitroblue tetrazolium assay.
ig. 3c shows that low concentrations of sulphated polysaccharides
xhibited dose-dependent scavenging activity against superox-
de anions, with Go3 reaching ∼33%, G3d 44% and EHW-I 55% at
0 g/mL.
. Discussion
In some circumstances, the macrophages are host cells to cer-
ain intracellular parasites, as Leishmania.  Compounds that can act
n macrophages are targets of study to give leishmanicidal activ-
ty [6]. Some polysaccharides are known as biological response
odulators by exert their effects on immunological system cells,
s macrophages [9]. In the present work, all the polysaccharides
ested exhibited signiﬁcant antileishmanial effects (Table 1). Our
esults suggest that the antileishmanial activity of Go3, G3d and
HW-I may  be due the signiﬁcant activation of the nitric oxide
athway in peritoneal macrophages, since all them showed expres-
ive increase in the NO production (Fig. 2). Noleto [17] suggested
hat the increase in 40% on NO production was responsible for the
ig. 3. Effects of Go3, G3d and EHW-I on superoxide anion production by mouse perit
xposed for 2 h to the polysaccharides Go3, G3d and EHW-I diluted in reaction medium
b).  The results are expressed as mean ± SE (n = 4, each experiment in quadruplicate). *p ≤
nion  scavenging activity of Go3, G3d and EHW-I. The results are expressed as mean ± SD
ontrol  (medium).3d and EHW-I. Nitric oxide production determined by nitrite dosage by the Griess
 0.05 signiﬁcant difference from negative control (medium).
leishmanicidal effects of GMPOLY. Ghosh [6] showed that the pro-
duction of NO from macrophages treated with the antileishmanial
drugs in the current use is necessary to their leishmanicidal activity.
An important point is that the leishmanicidal mechanisms showed
by various compounds, including pentavalent antimonials, are not
well understood yet. It has been proposed that the effect of anti-
mony sodium gluconate occurs in two  steps; the ﬁrst is observed
after 6 h of treatment and involves the production of reactive oxy-
gen species, while the second is observed after 24–48 h of treatment
and is dependent on NO production [39].
The antileishmanial activity of ARAGAL (10 g/mL) was con-
ﬁrmed by its signiﬁcant inhibition of ∼88% of Leishmania (L.)
amazonensis growth. This effect was slightly higher than that of
Meglumine Antimoniate (300 g/mL), which showed ∼79% inhi-
bition of Leishmania (L.) amazonensis growth when compared to
the medium (Table 1). Interestingly, this arabinogalactan showed
considerable leishmanicidal activity, but had no effect on the NO
pathway (Fig. 4b). Thus, its effect against amastigote forms of Leish-
mania is probably due to the activation of respiratory burst and
TNF- production previously observed in macrophages of mice
treated with the polysaccharide [12,16]. The results observed for
ARAGAL are in accordance with those was previously described for
an arabinogalactan extracted from E. purpurea, which showed 86.4%
inhibition of growth of intracellular L. enrietti in 24 h of treatment
at 250 g/mL [40]. The authors proposed that its leishmanicidal
oneal macrophages and their scavenging capacity. Peritoneal macrophages were
, consisting of cytochrome c 80 M in HBSS, without (a) or with 1 g/mL of PMA
 0.05 signiﬁcant difference from negative control. Figure (c) shows the superoxide
 (n = 3, each experiment in triplicate). *p ≤ 0.05 signiﬁcant difference from negative
M.M. Kangussu-Marcolino et al. / International Journal 
Fig. 4. Effects of ARAGAL on peritoneal macrophages. Peritoneal macrophages were
exposed for 48 h to ARAGAL at the indicated concentrations. (a) Cell viability was
determined by MTT  assay. Culture medium was  used as negative control, corre-
sponding to 100% viability. The results are expressed as mean ± SD (n = 3, each
experiment in quadruplicate). (b) Nitric oxide production determined by nitrite
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xperiment in triplicate). *p ≤ 0.05 signiﬁcant difference from negative control
medium).
ctivity might be due to the increase on the production of oxygen
adicals, which was observed in vitro and in vivo. It also stimulated
he in vitro production of TNF- at a concentration of 250 g/mL,
hich was 640 times higher than the control (untreated cells). In
he same way, chitin microparticles exhibited leishmanicidal in
itro effects on mice macrophages, activating TNF- production,
ut they were not able to increase NO levels [41].
To investigate the involvement of the nitrogen and oxygen
athways in antileishmanial effects of the polysaccharides, we eval-
ated the effects of the sulphated polysaccharides Go3, G3d and
HW-I on production of reactive oxygen and nitrogen species in
hese cells. Nitric oxide production, which is one of the microbi-
idal pathways of activated macrophages [42], takes some time
o start because of the need for iNOS synthesis. This production
asts for long periods of time and contributes to eliminate phago-
ytized microorganisms, especially parasites such as Leishmania
42,43]. Go3 stimulated NO production, which is statistically equal
o the stimulation of LPS at 100 ng/mL (positive control), but did not
resent a dose-dependent proﬁle (Fig. 2). EHW-I and G3d were also
ffective in stimulating this pathway, but at a lower intensity than
o3. In fact, other sulphated polysaccharides, extracted from Ulva
igida, activated nitric oxide production in higher amounts than the
esulphated forms [44]. Also, in accordance to our data, Xiong [45]
emonstrated that the presence of sulphated groups promoted the
ncrease in NO and IL-1 beta production by macrophages.
In the present study, Go3, G3d, and EHW-I polysaccharides
romoted a decrease in O2•− produced by peritoneal macrophages
n 2 h (Fig. 3a and b), effect probably associated with their O2•−
cavenging ability showed in the assays of NBT reduction (Fig. 3c).
t has been reported that sulphated polysaccharides presenting
ifferent contents of sulphate groups exhibited higher scavenger
ctivity with the increase of sulphate content [46]. Our results
re in according with Xiong [45], since the scavenging activity
f Go3 (33%), G3d (44%), and EHW-I (55%) was  proportional toof Biological Macromolecules 81 (2015) 165–170 169
the content of sulphate in these polysaccharides, of 26.1%, 29.4%
and 31%, respectively. Although it has been proposed that the
scavenging property is inherent to a variety of carbohydrates
[46], the polysaccharide modulatory action may  occur by other
mechanisms without interference of the scavenger property. In
fact, Go3, G3d, and EHW-I were able to scavenge superoxide anion
produced by macrophages, but stimulated these cells to release
nitric oxide and also showed a leishmanicidal effect (Table 1). In
previous study, we  showed a similar proﬁle for a galactomannan
from the lichen of R. celastri (GMPOLY) [17].
The results of this study suggest that the antileishmanial effects
of the polysaccharides occur by different mechanisms. The leish-
manicidal activity of sulphated polysaccharides (Go3, G3d, and
EHW-I) can be due to the expressive increase in the NO produc-
tion by macrophages. But, for ARAGAL this effect can be attributed
to the stimulation of O2•− and TNF- production. Nowadays,
the main leishmanicidal mechanism proposed involves oxygen
and nitrogen species production, we  believe that an association
between sulphated and ARAGAL polysaccharides could potentiate
the antileishmania effects with lower concentrations.
However, despite of the evidences of the antileishmania effects
be due to activation of the of nitric oxide and superoxide anion path-
ways by sulphated and ARAGAL respectively, we cannot exclude the
involvement of another signalling pathway. It is known that dif-
ferent polysaccharides may  bind various receptors on the surface
of macrophages [15,47]. This interaction can trigger the activation
of molecular targets, resulting in intracellular contributions to the
leishmanicidal effect. Thus, studies to investigate the leishmanici-
dal mechanism of action of these polysaccharides are in progress
in our laboratory.
5. Conclusion
Go3, G3d and EHW-I increased nitric oxide production, which is
probably related to the important leishmanicidal activity of these
polymers. In the other hand, ARAGAL exhibited a pronounced leish-
manicidal activity in spite of not affecting NO production.
Sulphated polysaccharides reduced the superoxide anion levels
in the absence and presence of PMA, probably due its superoxide
anion scavenging activity. These results indicate that the different
structures of these polysaccharides act by different mechanisms
in macrophages, but the ﬁnal outcome against leishmaniasis indi-
cates a promising potential for the development of new alternative
therapeutic agents against this disease.
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